Sign in
Multi-Institutional Randomized Double-Blind Phase II Trial of Everolimus vs. Placebo as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
Journal article

Multi-Institutional Randomized Double-Blind Phase II Trial of Everolimus vs. Placebo as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

C.A.O Nathan, D.N Hayes, O Harismendy, J Flores, T Moore-Medlin, J.S Gutkind, P Neupane, G Mills, Z.B Sargi, T.Y Seiwert, …
International journal of radiation oncology, biology, physics, Vol.106(5), pp.1116-1116
2020-04-01

Metrics

23 Record Views

Details